Isima, Nikita
Gil, Jesús http://orcid.org/0000-0002-4303-6260
Article History
First Online: 30 March 2023
Competing interests
: J.G. has acted as a consultant for Unity Biotechnology, Geras Bio, Myricx Pharma and Merck KGaA. Pfizer and Unity Biotechnology have funded research in J.G.’s laboratory (unrelated to the work presented here). J.G. owns equity in Geras Bio. J.G. is a named inventor in MRC and Imperial College patents, both related to senolytic therapies (the patents are no related to the work presented here). N.I. declares no competing interests.